Everest Medicines Announces Top-line Results from Phase 1 Clinical Trial of Taniborbactam in Combination with Cefepime in China

NEXT STORY
Data Science Impacting the Pharmaceutical Industry, 2020 Report – Accelerating COVID-19 Drug Discovery with AI and Data Science
PREV STORY
TVO Supports Students, Educators and Parents During Back-to-School
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Monopar Therapeutics Reports Second Quarter 2021 Financial Results and Recent Business Updates

author_avatar
NASDAQ Market News

ETST Announces the Execution of a Binding LOI to Acquire 100% of the Assets of a Canadian Biotech Company Specializing in Medical Devices, Testing and Vaccines and Forms New Wholly Owned Subsidiary, Earth Science Pharmaceutical, Inc.

Boca Raton, June 20, 2016 (GLOBE NEWSWIRE) --  Earth Science Tech, Inc. (OTCQB: ETST) ...

author_avatar
NASDAQ Market News

Positive clinical phase III results of vortioxetine in Japanese adults with Major Depressive Disorder

New clinical phase III data from a study conducted in Japan demonstrate the efficacy ...

author_avatar
NASDAQ Market News